PD65-10 PRLZ INCREASES PROSTATE CANCER DOCETAXEL RESISTANCE BY INHIBITING LKB1/AMPK-MEDIATED AUTOPHAGY

Jin Zeng,Wei Liu,Yizeng Fan,Dalin He,Lei Li

DOI: https://doi.org/10.1016/j.juro.2018.02.2994

2018-01-01

Abstract:You have accessJournal of UrologyProstate Cancer: Basic Research & Pathophysiology IV1 Apr 2018PD65-10 PRLZ INCREASES PROSTATE CANCER DOCETAXEL RESISTANCE BY INHIBITING LKB1/AMPK-MEDIATED AUTOPHAGY Jin Zeng, Wei Liu, Yizeng Fan, Dalin He, and Lei Li Jin ZengJin Zeng More articles by this author , Wei LiuWei Liu More articles by this author , Yizeng FanYizeng Fan More articles by this author , Dalin HeDalin He More articles by this author , and Lei LiLei Li More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2018.02.2994AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Docetaxel-mediated chemotherapy is the first-line standard approach and has been determined to show a survival advantage for metastatic castration-resistant prostate cancer (mCRPC) patients. However, a substantial proportion of patients eventually becomes refractory due to drug resistance. The detailed mechanisms remain unclear. We have previously reported that Prostate Leucine Zipper (PrLZ), a specific oncogene of prostate cancer (PCa), promotes PCa cell growth at the castration-resistant stage, thus suggesting a vital role of PrLZ in the progression of CRPC. In this study, we aimed to investigate the role of PrLZ in docetaxel resistance in PCa, focusing on PrLZ-regulating autophagy pathway. METHODS Human PCa PC3, LNCaP and C4-2 cell lines were used as the model system in vitro and PCa xenografts and PrLZ-knockout mice were used as the model system in vivo. Docetaxel-induced cell death and apoptosis in PCa were determined by MTT and flow cytometry assay. The effects of PrLZ on autophagy were determined by LC3 conversion, LC3 turnover, and LC3-GFP-RFP puncta assay. The role of PrLZ in the regulation of autophagy and liver kinase B1/AMP-activated protein kinase (LKB1/AMPK) signaling pathway was analyzed using immunoblotting, immunoprecipitation, siRNA silencing and plasmid overexpression. RESULTS PrLZ increased docetaxel-mediated drug resistance in PCa both in vitro and in vivo. PrLZ was involved in both glucose starvation and docetaxel-induced autophagy. Mechanistic dissection revealed that PrLZ interacted with LKB1 and further inhibited the activation of LKB1/AMPK signals, which negatively contributed to the induction of autophagy. Moreover, PrLZ/LKB1-mediated autophagy conferred resistance to docetaxel-induced cell death and apoptosis both in vitro and in vivo. CONCLUSIONS These findings identify a novel role of PrLZ in autophagy manipulation and provide new insight into docetaxel chemoresistance in PCa, suggesting a new strategy for treating mCRPC by targeting this newly identified signaling pathway. © 2018FiguresReferencesRelatedDetails Volume 199Issue 4SApril 2018Page: e1228-e1229 Advertisement Copyright & Permissions© 2018MetricsAuthor Information Jin Zeng More articles by this author Wei Liu More articles by this author Yizeng Fan More articles by this author Dalin He More articles by this author Lei Li More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...